EyePoint EYPT
NASDAQ EYPT
$3.24 +0.01 (+0.28%)
As of: Oct 2, 2026 · 3:20 PM EDT

EyePoint (EYPT) Depreciation & Amortization (CF) (2010 - 2026)

Updated

EyePoint (EYPT) posted Depreciation & Amortization (CF) of $690,000 for Q2 2026, up 28.3% from $538,000 a year earlier and up 8.5% from the prior quarter.

Analysis

EyePoint (EYPT) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at EyePoint was $2.39 million, up 25.2% year-over-year; for FY2025, it was $2.31 million, up 49.9% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for seven consecutive years, with a five-year compound annual growth rate of 65.0% (FY2020 to FY2025).
  • In prior years, EyePoint's Depreciation & Amortization (CF) was $1.54 million in FY2024 (+208.0%), $500,000 in FY2023 (+25.0%), $400,000 in FY2022 (+28.6%) and $311,000 in FY2021 (+64.6%).
  • The Q2 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) in data going back to Q4 2018.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last 25 quarters, with growth averaging 85.6% over the last eight quarters.
  • Across the past five years, year-over-year growth in Depreciation & Amortization (CF) ran from 4.7% in Q4 2025 to 254.8% in Q3 2024.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $636,000 (Q1 2026), $489,000 (Q4 2025) and $576,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 EyePoint 277.89 Mn -635.23 Mn 507,000.00 690,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 690,000.00
Mar 31, 2026 636,000.00
Dec 31, 2025 489,000.00
Sep 30, 2025 576,000.00
Jun 30, 2025 538,000.00
Mar 31, 2025 497,000.00
Dec 31, 2024 467,000.00
Sep 30, 2024 408,000.00
Jun 30, 2024 362,000.00
Mar 31, 2024 303,000.00
Dec 31, 2023 148,000.00
Sep 30, 2023 115,000.00
Jun 30, 2023 132,000.00
Mar 31, 2023 105,000.00
Dec 31, 2022 134,000.00
Sep 30, 2022 96,000.00
Jun 30, 2022 89,000.00
Mar 31, 2022 81,000.00
Dec 31, 2021 83,000.00
Sep 30, 2021 86,000.00
API Access

EyePoint Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=EYPT&period=max&api_key=YOUR_API_KEY